RAC 2.20% $1.78 race oncology ltd

"And now it's all up to shareholders if we want to fund...

  1. 3,299 Posts.
    lightbulb Created with Sketch. 360
    "And now it's all up to shareholders if we want to fund AML+Decitabine in a low dose setting, you know, like the trial we coughed up for in 2021."

    My point exactly - but better executed.
    Last edited by djbenton75: 23/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.